ID   GLPK_ECOLI              Reviewed;         502 AA.
AC   P0A6F3; P08859; Q2M8M2; Q59381;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 105.
DE   RecName: Full=Glycerol kinase {ECO:0000255|HAMAP-Rule:MF_00186};
DE            EC=2.7.1.30 {ECO:0000255|HAMAP-Rule:MF_00186};
DE   AltName: Full=ATP:glycerol 3-phosphotransferase {ECO:0000255|HAMAP-Rule:MF_00186};
DE   AltName: Full=Glycerokinase {ECO:0000255|HAMAP-Rule:MF_00186};
DE            Short=GK {ECO:0000255|HAMAP-Rule:MF_00186};
GN   Name=glpK {ECO:0000255|HAMAP-Rule:MF_00186};
GN   OrderedLocusNames=b3926, JW3897;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 2-24, FUNCTION,
RP   AND INDUCTION.
RX   PubMed=2826434;
RA   Pettigrew D.W., Ma D.-P., Conrad C.A., Johnson J.R.;
RT   "Escherichia coli glycerol kinase. Cloning and sequencing of the glpK
RT   gene and the primary structure of the enzyme.";
RL   J. Biol. Chem. 263:135-139(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1372899;
RA   Weissenborn D.L., Wittekindt N., Larson T.J.;
RT   "Structure and regulation of the glpFK operon encoding glycerol
RT   diffusion facilitator and glycerol kinase of Escherichia coli K-12.";
RL   J. Biol. Chem. 267:6122-6131(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8346018; DOI=10.1093/nar/21.15.3391;
RA   Plunkett G. III, Burland V., Daniels D.L., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome. III. DNA sequence of the
RT   region from 87.2 to 89.2 minutes.";
RL   Nucleic Acids Res. 21:3391-3398(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-31.
RX   PubMed=2544860;
RA   Muramatsu S., Mizuno T.;
RT   "Nucleotide sequence of the region encompassing the glpKF operon and
RT   its upstream region containing a bent DNA sequence of Escherichia
RT   coli.";
RL   Nucleic Acids Res. 17:4378-4378(1989).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-14.
RC   STRAIN=K12;
RX   PubMed=8899705; DOI=10.1111/j.1365-2958.1996.tb02652.x;
RA   Gonzalez-Gil G., Bringmann P., Kahmann R.;
RT   "FIS is a regulator of metabolism in Escherichia coli.";
RL   Mol. Microbiol. 22:21-29(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND MUTANT GLPK22.
RX   PubMed=8631672; DOI=10.1128/jb.178.10.2846-2852.1996;
RA   Pettigrew D.W., Liu W.Z., Holmes C., Meadow N.D., Roseman S.;
RT   "A single amino acid change in Escherichia coli glycerol kinase
RT   abolishes glucose control of glycerol utilization in vivo.";
RL   J. Bacteriol. 178:2846-2852(1996).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=5328677; DOI=10.1126/science.153.3737.755;
RA   Zwaig N., Lin E.C.;
RT   "Feedback inhibition of glycerol kinase, a catabolic enzyme in
RT   Escherichia coli.";
RL   Science 153:755-757(1966).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=5335908;
RA   Hayashi S.I., Lin E.C.;
RT   "Purification and properties of glycerol kinase from Escherichia
RT   coli.";
RL   J. Biol. Chem. 242:1030-1035(1967).
RN   [11]
RP   SUBUNIT.
RX   PubMed=4934840;
RA   Thorner J.W., Paulus H.;
RT   "Composition and subunit structure of glycerol kinase from Escherichia
RT   coli.";
RL   J. Biol. Chem. 246:3885-3894(1971).
RN   [12]
RP   FUNCTION, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=4575199;
RA   Thorner J.W., Paulus H.;
RT   "Catalytic and allosteric properties of glycerol kinase from
RT   Escherichia coli.";
RL   J. Biol. Chem. 248:3922-3932(1973).
RN   [13]
RP   SUBUNIT.
RX   PubMed=215194; DOI=10.1021/bi00617a010;
RA   de Riel J.K., Paulus H.;
RT   "Subunit dissociation in the allosteric regulation of glycerol kinase
RT   from Escherichia coli. 1. Kinetic evidence.";
RL   Biochemistry 17:5134-5140(1978).
RN   [14]
RP   SUBUNIT, AND ENZYME REGULATION.
RX   PubMed=215195; DOI=10.1021/bi00617a011;
RA   de Riel J.K., Paulus H.;
RT   "Subunit dissociation in the allosteric regulation of glycerol kinase
RT   from Escherichia coli. 2. Physical evidence.";
RL   Biochemistry 17:5141-5146(1978).
RN   [15]
RP   ENZYME REGULATION.
RX   PubMed=31903; DOI=10.1021/bi00617a012;
RA   de Riel J.K., Paulus H.;
RT   "Subunit dissociation in the allosteric regulation of glycerol kinase
RT   from Escherichia coli. 3. Role in desensitization.";
RL   Biochemistry 17:5146-5150(1978).
RN   [16]
RP   ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2985549;
RA   Novotny M.J., Frederickson W.L., Waygood E.B., Saier M.H. Jr.;
RT   "Allosteric regulation of glycerol kinase by enzyme IIIglc of the
RT   phosphotransferase system in Escherichia coli and Salmonella
RT   typhimurium.";
RL   J. Bacteriol. 162:810-816(1985).
RN   [17]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [18]
RP   MALONYLATION AT LYS-233.
RC   STRAIN=K12;
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH EIIA-GLC AND
RP   ADP, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=8430315; DOI=10.1126/science.8430315;
RA   Hurley J.H., Faber H.R., Worthylake D., Meadow N.D., Roseman S.,
RA   Pettigrew D.W., Remington S.J.;
RT   "Structure of the regulatory complex of Escherichia coli IIIGlc with
RT   glycerol kinase.";
RL   Science 259:673-677(1993).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) IN COMPLEX WITH EIIA-GLC;
RP   SUBSTRATES AND ZINC ION, AND SUBUNIT.
RX   PubMed=8170944; DOI=10.1073/pnas.91.9.3544;
RA   Feese M., Pettigrew D.W., Meadow N.D., Roseman S., Remington S.J.;
RT   "Cation-promoted association of a regulatory and target protein is
RT   controlled by protein phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3544-3548(1994).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, MUTAGENESIS OF ARG-237, ENZYME REGULATION, AND SUBUNIT.
RX   PubMed=9843423; DOI=10.1021/bi981616s;
RA   Ormoe M., Bystrom C.E., Remington S.J.;
RT   "Crystal structure of a complex of Escherichia coli glycerol kinase
RT   and an allosteric effector fructose 1,6-bisphosphate.";
RL   Biochemistry 37:16565-16572(1998).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.37 ANGSTROMS) OF MUTANT THR-66 IN COMPLEX
RP   WITH SUBSTRATE AND OF MUTANT ASP-475 IN COMPLEX WITH EIIA-GLC,
RP   MUTAGENESIS OF ALA-66; ILE-475 AND ARG-480, ENZYME REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=9817843; DOI=10.1016/S0969-2126(98)00140-3;
RA   Feese M.D., Faber H.R., Bystrom C.E., Pettigrew D.W., Remington S.J.;
RT   "Glycerol kinase from Escherichia coli and an Ala65-->Thr mutant: the
RT   crystal structures reveal conformational changes with implications for
RT   allosteric regulation.";
RL   Structure 6:1407-1418(1998).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF MUTANT TRP-59 IN COMPLEX WITH
RP   ATP ANALOGS, MUTAGENESIS OF SER-59, AND SUBUNIT.
RX   PubMed=10090737; DOI=10.1021/bi982460z;
RA   Bystrom C.E., Pettigrew D.W., Branchaud B.P., O'Brien P.,
RA   Remington S.J.;
RT   "Crystal structures of Escherichia coli glycerol kinase variant
RT   S58-->W in complex with nonhydrolyzable ATP analogues reveal a
RT   putative active conformation of the enzyme as a result of domain
RT   motion.";
RL   Biochemistry 38:3508-3518(1999).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF MUTANT ASP-231 IN COMPLEX
RP   WITH SUBSTRATE, MUTAGENESIS OF GLY-231, AND SUBUNIT.
RX   PubMed=17441732; DOI=10.1021/bi700096p;
RA   Anderson M.J., DeLabarre B., Raghunathan A., Palsson B.O.,
RA   Brunger A.T., Quake S.R.;
RT   "Crystal structure of a hyperactive Escherichia coli glycerol kinase
RT   mutant Gly230 --> Asp obtained using microfluidic crystallization
RT   devices.";
RL   Biochemistry 46:5722-5731(2007).
CC   -!- FUNCTION: Key enzyme in the regulation of glycerol uptake and
CC       metabolism. Catalyzes the phosphorylation of glycerol to yield sn-
CC       glycerol 3-phosphate. It also catalyzes the phosphorylation of
CC       dihydroxyacetone, L-glyceraldehyde and D-glyceraldehyde. It uses
CC       only ATP. {ECO:0000255|HAMAP-Rule:MF_00186,
CC       ECO:0000269|PubMed:2826434, ECO:0000269|PubMed:4575199,
CC       ECO:0000269|PubMed:5335908}.
CC   -!- CATALYTIC ACTIVITY: ATP + glycerol = ADP + sn-glycerol 3-
CC       phosphate. {ECO:0000255|HAMAP-Rule:MF_00186,
CC       ECO:0000269|PubMed:5335908}.
CC   -!- ENZYME REGULATION: Activity of this regulatory enzyme is affected
CC       by several metabolites. The non-competitive allosteric inhibition
CC       by fructose 1,6-bisphosphate (FBP) causes alterations in the
CC       quaternary structure of the enzyme. FBP inhibition requires that
CC       the enzyme exist only in a tetrameric state. Salt such as KCl
CC       reduces the affinity of the tetrameric form of the enzyme for FBP.
CC       Unphosphorylated phosphocarrier protein EIIA-Glc (III-Glc), an
CC       integral component of the bacterial phosphotransferase (PTS)
CC       system, also inhibits non-competitively and allostericaly the
CC       activity. Unlike FBP, both the dimer and the tetramer appear to be
CC       fully sensitive to enzyme EIIA-Glc inhibition. Zn(+2) greatly
CC       enhances the inhibitory potency of EIIA-Glc. Both allosteric
CC       regulatory agents is strongly pH dependent, with maximal
CC       inhibition occurring at pH 6.5. {ECO:0000269|PubMed:215195,
CC       ECO:0000269|PubMed:2985549, ECO:0000269|PubMed:31903,
CC       ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5328677,
CC       ECO:0000269|PubMed:8430315, ECO:0000269|PubMed:9817843,
CC       ECO:0000269|PubMed:9843423}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.3 uM for glycerol {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC         KM=400 uM for D-glyceraldehyde {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC         KM=500 uM for dihydroxyacetone {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC         KM=3 mM for L-glyceraldehyde {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC         KM=4 mM for ATP {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC       pH dependence:
CC         Optimum pH is 9.8. {ECO:0000269|PubMed:2985549,
CC         ECO:0000269|PubMed:4575199, ECO:0000269|PubMed:5335908,
CC         ECO:0000269|PubMed:9817843};
CC   -!- PATHWAY: Polyol metabolism; glycerol degradation via glycerol
CC       kinase pathway; sn-glycerol 3-phosphate from glycerol: step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_00186}.
CC   -!- SUBUNIT: Homotetramer and homodimer (in equilibrium). Heterodimer
CC       with EIIA-Glc (crr). Binds 1 zinc ion per glycerol kinase EIIA-Glc
CC       dimer. The zinc ion is important for dimerization.
CC       {ECO:0000255|HAMAP-Rule:MF_00186, ECO:0000269|PubMed:10090737,
CC       ECO:0000269|PubMed:17441732, ECO:0000269|PubMed:215194,
CC       ECO:0000269|PubMed:215195, ECO:0000269|PubMed:4934840,
CC       ECO:0000269|PubMed:8170944, ECO:0000269|PubMed:8430315,
CC       ECO:0000269|PubMed:9817843, ECO:0000269|PubMed:9843423}.
CC   -!- INDUCTION: By L-alpha-glycerol 3-phosphate.
CC       {ECO:0000269|PubMed:2826434}.
CC   -!- SIMILARITY: Belongs to the FGGY kinase family. {ECO:0000255|HAMAP-
CC       Rule:MF_00186}.
CC   -!- WEB RESOURCE: Name=Worthington enzyme manual;
CC       URL="http://www.worthington-biochem.com/GKEC/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18393; AAA23913.1; -; Genomic_DNA.
DR   EMBL; M55990; AAA23887.1; -; Genomic_DNA.
DR   EMBL; L19201; AAB03058.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76908.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77384.1; -; Genomic_DNA.
DR   EMBL; X15054; CAA33154.1; -; Genomic_DNA.
DR   EMBL; U41468; AAB60196.1; -; Genomic_DNA.
DR   PIR; A27339; KIECGL.
DR   RefSeq; NP_418361.1; NC_000913.3.
DR   RefSeq; WP_000136788.1; NZ_LN832404.1.
DR   PDB; 1BO5; X-ray; 3.20 A; O/Z=2-502.
DR   PDB; 1BOT; X-ray; 3.05 A; O/Z=2-502.
DR   PDB; 1BU6; X-ray; 2.37 A; O/X/Y/Z=2-502.
DR   PDB; 1BWF; X-ray; 3.00 A; O/Y=2-502.
DR   PDB; 1GLA; X-ray; 2.60 A; G=2-502.
DR   PDB; 1GLB; X-ray; 2.60 A; G=2-502.
DR   PDB; 1GLC; X-ray; 2.65 A; G=2-502.
DR   PDB; 1GLD; X-ray; 2.93 A; G=2-502.
DR   PDB; 1GLE; X-ray; 2.94 A; G=2-502.
DR   PDB; 1GLF; X-ray; 2.62 A; O/X/Y/Z=2-502.
DR   PDB; 1GLJ; X-ray; 3.00 A; O/Y=2-502.
DR   PDB; 1GLL; X-ray; 3.00 A; O/Y=2-502.
DR   PDB; 3EZW; X-ray; 2.00 A; A/B/C/D/E/F/G/H=2-501.
DR   PDBsum; 1BO5; -.
DR   PDBsum; 1BOT; -.
DR   PDBsum; 1BU6; -.
DR   PDBsum; 1BWF; -.
DR   PDBsum; 1GLA; -.
DR   PDBsum; 1GLB; -.
DR   PDBsum; 1GLC; -.
DR   PDBsum; 1GLD; -.
DR   PDBsum; 1GLE; -.
DR   PDBsum; 1GLF; -.
DR   PDBsum; 1GLJ; -.
DR   PDBsum; 1GLL; -.
DR   PDBsum; 3EZW; -.
DR   ProteinModelPortal; P0A6F3; -.
DR   SMR; P0A6F3; -.
DR   BioGrid; 4263162; 380.
DR   DIP; DIP-36011N; -.
DR   IntAct; P0A6F3; 15.
DR   STRING; 511145.b3926; -.
DR   SWISS-2DPAGE; P0A6F3; -.
DR   EPD; P0A6F3; -.
DR   PaxDb; P0A6F3; -.
DR   PRIDE; P0A6F3; -.
DR   EnsemblBacteria; AAC76908; AAC76908; b3926.
DR   EnsemblBacteria; BAE77384; BAE77384; BAE77384.
DR   GeneID; 948423; -.
DR   KEGG; ecj:JW3897; -.
DR   KEGG; eco:b3926; -.
DR   PATRIC; 32123365; VBIEscCol129921_4043.
DR   EchoBASE; EB0393; -.
DR   EcoGene; EG10398; glpK.
DR   eggNOG; ENOG4107QVN; Bacteria.
DR   eggNOG; COG0554; LUCA.
DR   HOGENOM; HOG000222134; -.
DR   InParanoid; P0A6F3; -.
DR   KO; K00864; -.
DR   OMA; PMEIFAT; -.
DR   PhylomeDB; P0A6F3; -.
DR   BioCyc; EcoCyc:GLYCEROL-KIN-MONOMER; -.
DR   BioCyc; MetaCyc:GLYCEROL-KIN-MONOMER; -.
DR   BRENDA; 2.7.1.30; 2026.
DR   UniPathway; UPA00618; UER00672.
DR   EvolutionaryTrace; P0A6F3; -.
DR   PRO; PR:P0A6F3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004370; F:glycerol kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IDA:EcoCyc.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoliWiki.
DR   GO; GO:0019563; P:glycerol catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006071; P:glycerol metabolic process; IDA:UniProtKB.
DR   GO; GO:0006072; P:glycerol-3-phosphate metabolic process; IEA:InterPro.
DR   GO; GO:0016310; P:phosphorylation; IDA:EcoCyc.
DR   HAMAP; MF_00186; Glycerol_kin; 1.
DR   InterPro; IPR000577; Carb_kinase_FGGY.
DR   InterPro; IPR018485; Carb_kinase_FGGY_C.
DR   InterPro; IPR018483; Carb_kinase_FGGY_CS.
DR   InterPro; IPR018484; Carb_kinase_FGGY_N.
DR   InterPro; IPR005999; Glycerol_kin.
DR   Pfam; PF02782; FGGY_C; 1.
DR   Pfam; PF00370; FGGY_N; 1.
DR   PIRSF; PIRSF000538; GlpK; 1.
DR   TIGRFAMs; TIGR01311; glycerol_kin; 1.
DR   PROSITE; PS00933; FGGY_KINASES_1; 1.
DR   PROSITE; PS00445; FGGY_KINASES_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Glycerol metabolism; Kinase; Metal-binding;
KW   Nucleotide-binding; Reference proteome; Transferase; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2826434,
FT                                ECO:0000269|PubMed:8899705}.
FT   CHAIN         2    502       Glycerol kinase.
FT                                /FTId=PRO_0000059451.
FT   NP_BIND      14     16       ATP.
FT   NP_BIND     412    416       ATP.
FT   REGION       84     85       Substrate binding.
FT   REGION      234    236       Allosteric FBP inhibitor binding.
FT   REGION      246    247       Substrate binding.
FT   METAL       479    479       Zinc; shared with EIIA-Glc.
FT   BINDING      14     14       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00186,
FT                                ECO:0000269|PubMed:17441732}.
FT   BINDING      18     18       ATP.
FT   BINDING     136    136       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00186,
FT                                ECO:0000269|PubMed:17441732}.
FT   BINDING     268    268       ATP.
FT   BINDING     311    311       ATP; via carbonyl oxygen.
FT   BINDING     315    315       ATP; via amide nitrogen.
FT   BINDING     330    330       ATP.
FT   MOD_RES     233    233       N6-malonyllysine.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MUTAGEN      59     59       S->W: Abolishes inhibition of GK by FBP
FT                                via disruption of the dimer-tetramer
FT                                assembly reaction. Inhibition by EIIA-Glc
FT                                is unchanged compared to wild type. The
FT                                activity of this mutant is significantly
FT                                higher than wild-type, and the Michaelis
FT                                constants are increased slightly compared
FT                                to wild-type.
FT                                {ECO:0000269|PubMed:10090737}.
FT   MUTAGEN      66     66       A->T: Although it completely abolishes
FT                                FBP regulation and disruptes dimer-
FT                                tetramer equilibrium, the crystal
FT                                structure is essentially identical to the
FT                                symmetric tetramer found in the FBP-bound
FT                                form of the enzyme.
FT                                {ECO:0000269|PubMed:9817843}.
FT   MUTAGEN     231    231       G->D: Displays an increased enzymatic
FT                                activity and a decreased allosteric
FT                                regulation by FBP compared to wild-type.
FT                                It displays a dimer form and is resistant
FT                                to tetramer formation in the presence of
FT                                FBP, whereas wild-type dimers are
FT                                converted into inactive tetramers in the
FT                                presence of FBP.
FT                                {ECO:0000269|PubMed:17441732}.
FT   MUTAGEN     237    237       R->A: Drastically reduces inhibition of
FT                                GK by FBP and lowers, but did not
FT                                eliminate, the ability of FBP to promote
FT                                tetramer association.
FT                                {ECO:0000269|PubMed:9843423}.
FT   MUTAGEN     305    305       G->S: In glpK22; abolishes glucose
FT                                control of glycerol utilization.
FT   MUTAGEN     475    475       I->D: It decreases Vmax to about 10% of
FT                                the wild-type value and the affinity for
FT                                substrate is increased about two- to
FT                                fourfold. This mutation decreases the
FT                                catalytic activity in a manner that is
FT                                analogous to that obtained upon EIIA-Glc
FT                                binding. It increases the affinity for
FT                                FBP about fivefold.
FT                                {ECO:0000269|PubMed:9817843}.
FT   MUTAGEN     480    480       R->D: It decreases Vmax to about 10% of
FT                                the wild-type value and the affinity for
FT                                substrate is increased about two- to
FT                                fourfold. This mutation decreases the
FT                                catalytic activity in a manner that is
FT                                analogous to that obtained upon EIIA-Glc
FT                                binding. Regulation by FBP is not
FT                                affected by this substitution. No
FT                                inhibition by EIIA-Glc is observed, which
FT                                is consistent with a decrease in affinity
FT                                for EIIA-Glc of about 250-fold.
FT                                {ECO:0000269|PubMed:9817843}.
FT   STRAND        6     12       {ECO:0000244|PDB:3EZW}.
FT   STRAND       14     22       {ECO:0000244|PDB:3EZW}.
FT   STRAND       24     26       {ECO:0000244|PDB:1GLA}.
FT   STRAND       28     35       {ECO:0000244|PDB:3EZW}.
FT   STRAND       41     44       {ECO:0000244|PDB:1GLA}.
FT   HELIX        50     68       {ECO:0000244|PDB:3EZW}.
FT   HELIX        72     74       {ECO:0000244|PDB:3EZW}.
FT   STRAND       75     82       {ECO:0000244|PDB:3EZW}.
FT   STRAND       87     91       {ECO:0000244|PDB:3EZW}.
FT   TURN         92     94       {ECO:0000244|PDB:3EZW}.
FT   STRAND       97     99       {ECO:0000244|PDB:3EZW}.
FT   HELIX       110    118       {ECO:0000244|PDB:3EZW}.
FT   TURN        119    121       {ECO:0000244|PDB:1BU6}.
FT   HELIX       122    129       {ECO:0000244|PDB:3EZW}.
FT   HELIX       138    148       {ECO:0000244|PDB:3EZW}.
FT   STRAND      149    151       {ECO:0000244|PDB:1GLA}.
FT   HELIX       152    157       {ECO:0000244|PDB:3EZW}.
FT   TURN        158    160       {ECO:0000244|PDB:1GLL}.
FT   STRAND      161    164       {ECO:0000244|PDB:3EZW}.
FT   HELIX       166    174       {ECO:0000244|PDB:3EZW}.
FT   TURN        175    177       {ECO:0000244|PDB:3EZW}.
FT   STRAND      181    183       {ECO:0000244|PDB:3EZW}.
FT   HELIX       184    187       {ECO:0000244|PDB:3EZW}.
FT   STRAND      190    194       {ECO:0000244|PDB:3EZW}.
FT   TURN        195    198       {ECO:0000244|PDB:3EZW}.
FT   HELIX       202    208       {ECO:0000244|PDB:3EZW}.
FT   HELIX       212    214       {ECO:0000244|PDB:3EZW}.
FT   STRAND      217    219       {ECO:0000244|PDB:3EZW}.
FT   STRAND      221    228       {ECO:0000244|PDB:3EZW}.
FT   STRAND      231    235       {ECO:0000244|PDB:1BU6}.
FT   STRAND      238    245       {ECO:0000244|PDB:3EZW}.
FT   HELIX       246    253       {ECO:0000244|PDB:3EZW}.
FT   STRAND      262    275       {ECO:0000244|PDB:3EZW}.
FT   STRAND      284    286       {ECO:0000244|PDB:3EZW}.
FT   STRAND      288    293       {ECO:0000244|PDB:3EZW}.
FT   TURN        295    297       {ECO:0000244|PDB:1GLC}.
FT   STRAND      299    308       {ECO:0000244|PDB:3EZW}.
FT   HELIX       311    319       {ECO:0000244|PDB:3EZW}.
FT   STRAND      326    328       {ECO:0000244|PDB:3EZW}.
FT   HELIX       330    334       {ECO:0000244|PDB:3EZW}.
FT   STRAND      337    339       {ECO:0000244|PDB:3EZW}.
FT   STRAND      344    346       {ECO:0000244|PDB:3EZW}.
FT   HELIX       348    350       {ECO:0000244|PDB:1GLL}.
FT   TURN        354    356       {ECO:0000244|PDB:3EZW}.
FT   STRAND      363    368       {ECO:0000244|PDB:3EZW}.
FT   HELIX       374    400       {ECO:0000244|PDB:3EZW}.
FT   STRAND      405    411       {ECO:0000244|PDB:3EZW}.
FT   HELIX       412    415       {ECO:0000244|PDB:3EZW}.
FT   HELIX       417    427       {ECO:0000244|PDB:3EZW}.
FT   STRAND      429    435       {ECO:0000244|PDB:3EZW}.
FT   HELIX       439    451       {ECO:0000244|PDB:3EZW}.
FT   STRAND      454    456       {ECO:0000244|PDB:3EZW}.
FT   HELIX       458    460       {ECO:0000244|PDB:3EZW}.
FT   TURN        461    463       {ECO:0000244|PDB:1GLF}.
FT   STRAND      467    471       {ECO:0000244|PDB:3EZW}.
FT   HELIX       477    494       {ECO:0000244|PDB:3EZW}.
SQ   SEQUENCE   502 AA;  56231 MW;  854B61EA4648AB80 CRC64;
     MTEKKYIVAL DQGTTSSRAV VMDHDANIIS VSQREFEQIY PKPGWVEHDP MEIWATQSST
     LVEVLAKADI SSDQIAAIGI TNQRETTIVW EKETGKPIYN AIVWQCRRTA EICEHLKRDG
     LEDYIRSNTG LVIDPYFSGT KVKWILDHVE GSRERARRGE LLFGTVDTWL IWKMTQGRVH
     VTDYTNASRT MLFNIHTLDW DDKMLEVLDI PREMLPEVRR SSEVYGQTNI GGKGGTRIPI
     SGIAGDQQAA LFGQLCVKEG MAKNTYGTGC FMLMNTGEKA VKSENGLLTT IACGPTGEVN
     YALEGAVFMA GASIQWLRDE MKLINDAYDS EYFATKVQNT NGVYVVPAFT GLGAPYWDPY
     ARGAIFGLTR GVNANHIIRA TLESIAYQTR DVLEAMQADS GIRLHALRVD GGAVANNFLM
     QFQSDILGTR VERPEVREVT ALGAAYLAGL AVGFWQNLDE LQEKAVIERE FRPGIETTER
     NYRYAGWKKA VKRAMAWEEH DE
//
